1. Home
  2. PSNL vs NMFC Comparison

PSNL vs NMFC Comparison

Compare PSNL & NMFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSNL
  • NMFC
  • Stock Information
  • Founded
  • PSNL 2011
  • NMFC 2010
  • Country
  • PSNL United States
  • NMFC United States
  • Employees
  • PSNL N/A
  • NMFC N/A
  • Industry
  • PSNL Medical Specialities
  • NMFC Finance/Investors Services
  • Sector
  • PSNL Health Care
  • NMFC Finance
  • Exchange
  • PSNL Nasdaq
  • NMFC Nasdaq
  • Market Cap
  • PSNL 854.8M
  • NMFC 983.8M
  • IPO Year
  • PSNL 2019
  • NMFC 2011
  • Fundamental
  • Price
  • PSNL $8.86
  • NMFC $9.66
  • Analyst Decision
  • PSNL Strong Buy
  • NMFC Hold
  • Analyst Count
  • PSNL 5
  • NMFC 3
  • Target Price
  • PSNL $8.70
  • NMFC $10.33
  • AVG Volume (30 Days)
  • PSNL 1.3M
  • NMFC 651.8K
  • Earning Date
  • PSNL 11-04-2025
  • NMFC 11-03-2025
  • Dividend Yield
  • PSNL N/A
  • NMFC 13.26%
  • EPS Growth
  • PSNL N/A
  • NMFC N/A
  • EPS
  • PSNL N/A
  • NMFC 0.65
  • Revenue
  • PSNL $80,317,000.00
  • NMFC $340,877,000.00
  • Revenue This Year
  • PSNL N/A
  • NMFC N/A
  • Revenue Next Year
  • PSNL $29.83
  • NMFC N/A
  • P/E Ratio
  • PSNL N/A
  • NMFC $14.87
  • Revenue Growth
  • PSNL 0.36
  • NMFC N/A
  • 52 Week Low
  • PSNL $2.83
  • NMFC $8.84
  • 52 Week High
  • PSNL $10.95
  • NMFC $12.05
  • Technical
  • Relative Strength Index (RSI)
  • PSNL 52.03
  • NMFC 51.41
  • Support Level
  • PSNL $9.40
  • NMFC $9.57
  • Resistance Level
  • PSNL $10.06
  • NMFC $9.76
  • Average True Range (ATR)
  • PSNL 0.89
  • NMFC 0.16
  • MACD
  • PSNL -0.18
  • NMFC 0.05
  • Stochastic Oscillator
  • PSNL 10.20
  • NMFC 70.99

About PSNL Personalis Inc.

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

About NMFC New Mountain Finance Corporation

New Mountain Finance Corp is a closed-end, non-diversified management investment company. It invests in equity interests such as preferred stock, common stock, warrants, or options received in connection with debt investments or may include direct investment in the equity of private companies. The company's investment objective is to generate current income and capital appreciation through sourcing and origination of debt securities at all levels of the capital structure, including first and second-lien debt, notes, bonds and mezzanine securities.

Share on Social Networks: